{
    "Trade/Device Name(s)": [
        "MAJOR III Blood Glucose Monitoring System"
    ],
    "Submitter Information": "BESTGEN Biotech Corp.",
    "510(k) Number": "K072274",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062538"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "February 29, 2008",
    "Summary Letter Received Date": "February 28, 2008",
    "Submission Date": "February 20, 2008",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Fresh capillary blood from the fingertip"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MAJOR III Blood Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for MAJOR III Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood using electrochemical biosensor technology.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary blood from the fingertip for use at home (OTC) or in clinical settings by health care professionals as an aid to monitor effectiveness of diabetes control.",
    "fda_folder": "Clinical Chemistry"
}